EXCLUSIVE: What’s Going On In Argentina? Technical Analyst Carlos Maslatón Dives In
Sergio Massa has assumed a central role in the management of the executive power in Argentina, taking control of three central ministries &mdash
Could Polygon’s New ZkEVM Be The Solution Ethereum Is Looking For? Interview With Jordi Baylina At EthCC 5
EthCC 5, an Ethereum (CRYPTO: ETH) community conference, took place at the Maison de la Mutualité in Paris this past week, and it did not disappoint.
Amazon’s Broken Promise — Here’s How The E-Commerce Giant Upset A NYC Suburb
As Amazon.com, Inc. (NASDAQ: AMZN) looks to grow its Last Mile Delivery initiative, the e-commerce giant is continuing to build warehouses all over the world.
Komodo CTO Kadan Stadelmann Talks AtomicDEX, ShibaDEX, Cosmos Integrations: What You Need To Know
Komodo’s flagship product, the AtomicDEX, has been in development since 2013. The decentralized exchange remains a topic of discussion as it continues to develop its interoperability while keeping safety as a core focus.
Ethereum’s Communication Layer EPNS: Interview With Co-Founder Harsh Rajat At EthCC 5 Paris
Harsh Rajat, the co-founder of Ethereum Push Notification Service (EPNS), sat down with Benzinga last week at the Ethereum (CRYPTO: ETH) community conference in Paris.
EXCLUSIVE: Wejo Consummates Additional $15.9M PIPE Investment, Announces Cost Savings Initiatives
Wejo Group Limited (NASDAQ: WEJO) completes a $15.9 million PIPE investment.
EXCLUSIVE: Gitcoin Founder Kevin Owocki Thinks A Bear Market Could Spark Innovation, Talks About Funding, Past Success Stories
Benzinga was given a chance to talk about Gitcoin's impact with its founder, Kevin Owocki, following his talk at EthCC 5, July 19-21, in Paris.
What Happened: This came after the most recent Gitcoin fundraising round closed raising just over $5.1 million.
EXCLUSIVE: Psychedelics-Assisted Psychotherapy Co. Bienstar Adds Renown Psychiatrist Dartiu Da Silveira As Scientific Advisor
Zinger Brief
Dr. Dartiu da Silveira is a renowned Brazilian psychiatrist and a pioneer in psychedelics scientific research.
Dr. Silveira will collaborate with Bienstar as a scientific advisor.
The advisor will focus on ibogaine assisted therapies protocols, medical education programs and clinical research development.
